Impact of COVID-19 on Antimicrobial Resistance

Rapid Review of the Global Impact of COVID-19 on the 3 Core Drivers of Antimicrobial Resistance

Project Status:Complete

Knowledge User(s)

Public Health Agency of Canada

Patient/Public Partner(s)

Amanda Doherty-Kirby, Michelle Quinlan

Project Trainee(s)

Fiona Emdin

Funding Source(s)

  • Canadian Institutes of Health Research (CIHR) through COVID-END
  • Public Health Agency of Canada

Project Objectives

To determine the impact of COVID-19 on antimicrobial resistance, in any population, setting or location, with an interest on exploring effects of COVID-19 driven changes in antimicrobial resistance, infection prevention and control measures, health system on the emergence, transmission or burden of antimicrobial resistance of any pathogen.

Research Approach

Living Evidence Synthesis

Project Lead(s)

Susan Rogers Van Katwyk

Position: Global Strategy Lab, York University

Susan Rogers Van Katwyk

Global Strategy Lab, York University

Julian Little

Position: School of Epidemiology and Public Health, University of Ottawa
Email: jlittle@uottawa.ca

Julian Little

School of Epidemiology and Public Health, University of Ottawa

Project Outputs

Report #1

Report #2 

Report #3